C

China Resources Pharmaceutical Group Ltd
HKEX:3320

Watchlist Manager
China Resources Pharmaceutical Group Ltd
HKEX:3320
Watchlist
Price: 5.5 HKD 1.29%
Market Cap: 34.6B HKD
Have any thoughts about
China Resources Pharmaceutical Group Ltd?
Write Note

Intrinsic Value

The intrinsic value of one China Resources Pharmaceutical Group Ltd stock under the Base Case scenario is 16.47 HKD. Compared to the current market price of 5.5 HKD, China Resources Pharmaceutical Group Ltd is Undervalued by 67%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
16.47 HKD
Undervaluation 67%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
China Resources Pharmaceutical Group Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for China Resources Pharmaceutical Group Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about China Resources Pharmaceutical Group Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

5.5 HKD
+1.29%
+1.29%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

China Resources Pharmaceutical Group Ltd
HK
Pharmaceuticals
Market Cap
34.6B HKD
IPO
Oct 28, 2016
Employees
64 000
Hong Kong
Market Cap
34.6B HKD
Industry
Pharmaceuticals
IPO
Oct 28, 2016
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about China Resources Pharmaceutical Group Ltd

Provide an overview of the primary business activities
of China Resources Pharmaceutical Group Ltd.

What unique competitive advantages
does China Resources Pharmaceutical Group Ltd hold over its rivals?

What risks and challenges
does China Resources Pharmaceutical Group Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for China Resources Pharmaceutical Group Ltd.

Provide P/S
for China Resources Pharmaceutical Group Ltd.

Provide P/E
for China Resources Pharmaceutical Group Ltd.

Provide P/OCF
for China Resources Pharmaceutical Group Ltd.

Provide P/FCFE
for China Resources Pharmaceutical Group Ltd.

Provide P/B
for China Resources Pharmaceutical Group Ltd.

Provide EV/S
for China Resources Pharmaceutical Group Ltd.

Provide EV/GP
for China Resources Pharmaceutical Group Ltd.

Provide EV/EBITDA
for China Resources Pharmaceutical Group Ltd.

Provide EV/EBIT
for China Resources Pharmaceutical Group Ltd.

Provide EV/OCF
for China Resources Pharmaceutical Group Ltd.

Provide EV/FCFF
for China Resources Pharmaceutical Group Ltd.

Provide EV/IC
for China Resources Pharmaceutical Group Ltd.

Show me price targets
for China Resources Pharmaceutical Group Ltd made by professional analysts.

What are the Revenue projections
for China Resources Pharmaceutical Group Ltd?

How accurate were the past Revenue estimates
for China Resources Pharmaceutical Group Ltd?

What are the Net Income projections
for China Resources Pharmaceutical Group Ltd?

How accurate were the past Net Income estimates
for China Resources Pharmaceutical Group Ltd?

What are the EPS projections
for China Resources Pharmaceutical Group Ltd?

How accurate were the past EPS estimates
for China Resources Pharmaceutical Group Ltd?

What are the EBIT projections
for China Resources Pharmaceutical Group Ltd?

How accurate were the past EBIT estimates
for China Resources Pharmaceutical Group Ltd?

Compare the revenue forecasts
for China Resources Pharmaceutical Group Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of China Resources Pharmaceutical Group Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of China Resources Pharmaceutical Group Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of China Resources Pharmaceutical Group Ltd compared to its peers.

Compare the P/E ratios
of China Resources Pharmaceutical Group Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing China Resources Pharmaceutical Group Ltd with its peers.

Analyze the financial leverage
of China Resources Pharmaceutical Group Ltd compared to its main competitors.

Show all profitability ratios
for China Resources Pharmaceutical Group Ltd.

Provide ROE
for China Resources Pharmaceutical Group Ltd.

Provide ROA
for China Resources Pharmaceutical Group Ltd.

Provide ROIC
for China Resources Pharmaceutical Group Ltd.

Provide ROCE
for China Resources Pharmaceutical Group Ltd.

Provide Gross Margin
for China Resources Pharmaceutical Group Ltd.

Provide Operating Margin
for China Resources Pharmaceutical Group Ltd.

Provide Net Margin
for China Resources Pharmaceutical Group Ltd.

Provide FCF Margin
for China Resources Pharmaceutical Group Ltd.

Show all solvency ratios
for China Resources Pharmaceutical Group Ltd.

Provide D/E Ratio
for China Resources Pharmaceutical Group Ltd.

Provide D/A Ratio
for China Resources Pharmaceutical Group Ltd.

Provide Interest Coverage Ratio
for China Resources Pharmaceutical Group Ltd.

Provide Altman Z-Score Ratio
for China Resources Pharmaceutical Group Ltd.

Provide Quick Ratio
for China Resources Pharmaceutical Group Ltd.

Provide Current Ratio
for China Resources Pharmaceutical Group Ltd.

Provide Cash Ratio
for China Resources Pharmaceutical Group Ltd.

What is the historical Revenue growth
over the last 5 years for China Resources Pharmaceutical Group Ltd?

What is the historical Net Income growth
over the last 5 years for China Resources Pharmaceutical Group Ltd?

What is the current Free Cash Flow
of China Resources Pharmaceutical Group Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for China Resources Pharmaceutical Group Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
China Resources Pharmaceutical Group Ltd

Current Assets 197.6B
Cash & Short-Term Investments 62B
Receivables 85.6B
Other Current Assets 50B
Non-Current Assets 68.8B
Long-Term Investments 8.6B
PP&E 24.8B
Intangibles 29.3B
Other Non-Current Assets 6.1B
Current Liabilities 144B
Accounts Payable 141.9B
Accrued Liabilities 3.7B
Other Current Liabilities -1.6B
Non-Current Liabilities 74B
Long-Term Debt 21.7B
Other Non-Current Liabilities 52.3B
Efficiency

Earnings Waterfall
China Resources Pharmaceutical Group Ltd

Revenue
373.3B HKD
Cost of Revenue
-314B HKD
Gross Profit
59.3B HKD
Operating Expenses
-39.6B HKD
Operating Income
19.6B HKD
Other Expenses
-13.2B HKD
Net Income
6.5B HKD

Free Cash Flow Analysis
China Resources Pharmaceutical Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

China Resources Pharmaceutical Group Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive 3-Years Revenue Growth
ROIC is Increasing
Positive Revenue Growth Forecast
ROE is Increasing
53/100
Profitability
Score

China Resources Pharmaceutical Group Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

China Resources Pharmaceutical Group Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
53/100
Solvency
Score

China Resources Pharmaceutical Group Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
China Resources Pharmaceutical Group Ltd

Wall Street analysts forecast China Resources Pharmaceutical Group Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Resources Pharmaceutical Group Ltd is 7.64 HKD with a low forecast of 5.96 HKD and a high forecast of 10.4 HKD.

Lowest
Price Target
5.96 HKD
8% Upside
Average
Price Target
7.64 HKD
39% Upside
Highest
Price Target
10.4 HKD
89% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for China Resources Pharmaceutical Group Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for China Resources Pharmaceutical Group Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one China Resources Pharmaceutical Group Ltd stock?

The intrinsic value of one China Resources Pharmaceutical Group Ltd stock under the Base Case scenario is 16.47 HKD.

Is China Resources Pharmaceutical Group Ltd stock undervalued or overvalued?

Compared to the current market price of 5.5 HKD, China Resources Pharmaceutical Group Ltd is Undervalued by 67%.

Back to Top